Cefprozil for Oral Suspension 250 mg/5 mL, Fasting
Clinical trial NCT00835614 · COMPLETED
Trial details
- NCT number
- NCT00835614
- Sponsor
- Teva Pharmaceuticals USA
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2004-04-01
- Primary completion
- 2004-04-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.